High prevalence of hepatitis C virus (HCV) RNA in dialysis patients: failure of commercially available antibody tests to identify a significant number of patients with HCV infection. Copenhagen Dialysis HCV Study Group.

PubWeight™: 1.16‹?› | Rank: Top 10%

🔗 View Article (PMID 7504031)

Published in J Infect Dis on December 01, 1993

Authors

J Bukh1, P Wantzin, K Krogsgaard, F Knudsen, R H Purcell, R H Miller

Author Affiliations

1: Hepatitis Viruses Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.

Articles citing this

Analysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profiles. J Virol (1998) 1.48

Hepatitis C: progress and problems. Clin Microbiol Rev (1994) 1.37

Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients. Gut (2002) 1.11

Prevalence and risk factors of hepatitis B and C viruses among haemodialysis patients in Gaza strip, Palestine. Virol J (2010) 1.04

Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patients. J Clin Microbiol (2005) 1.04

High incidence of hepatitis C virus infection in hemodialysis patients in units with high prevalence. J Clin Microbiol (1996) 1.00

Management of patients with hepatitis C infection and renal disease. World J Hepatol (2015) 0.95

Relevance of reactivity in commercially available hepatitis C virus antibody assays. J Clin Microbiol (2001) 0.93

Hepatitis C virus infections in dialysis centers in The Netherlands: a national survey by serological and molecular methods. J Clin Microbiol (1998) 0.92

Analysis of hepatitis C virus isolates by serotyping and genotyping. J Clin Microbiol (1996) 0.88

Prevalence of hepatitis C virus infection among hemodialysis patients at a tertiary-care hospital in Mexico City, Mexico. J Clin Microbiol (2004) 0.85

Detection of hepatitis C virus by PCR in second-generation enzyme immunoassay-seropositive blood donors by using matched pairs of fresh frozen plasma and pilot tube sera. J Clin Microbiol (1996) 0.82

HCV response in patients with end stage renal disease treated with combination pegylated interferon alpha-2a and ribavirin. J Clin Gastroenterol (2009) 0.78

Role of hepatitis C virus in chronic liver disease occurring after orthotopic liver transplantation. Arch Dis Child (1995) 0.76

Evaluation of an isolation program of hepatitis C virus infected hemodialysis patients in some hemodialysis centers in egypt. ISRN Nephrol (2012) 0.76

Hepatitis C Virus Infection in Patients with End-Stage Renal Disease: A Study from a Tertiary Care Centre in India. J Clin Exp Hepatol (2015) 0.75

Articles by these authors

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (1989) 18.79

One-step preparation of competent Escherichia coli: transformation and storage of bacterial cells in the same solution. Proc Natl Acad Sci U S A (1989) 11.49

DNA polymerase associated with human hepatitis B antigen. J Virol (1973) 10.71

Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc Natl Acad Sci U S A (1990) 8.92

Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med (1989) 8.10

A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium. Nature (1983) 6.52

A colour test for the measurement of antibody to certain mycoplasma species based upon the inhibition of acid production. J Hyg (Lond) (1966) 6.23

Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc Natl Acad Sci U S A (1997) 6.09

A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci U S A (1997) 6.07

Protective effect of antibody to parainfluenza type 1 virus. N Engl J Med (1966) 5.97

Color test for the measurement of antibody to T-strain mycoplasmas. J Bacteriol (1966) 5.61

Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis (1995) 5.53

Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci U S A (1991) 5.51

The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science (2000) 5.49

delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. Proc Natl Acad Sci U S A (1980) 5.12

An African primate lentivirus (SIVsm) closely related to HIV-2. Nature (1989) 5.03

Lack of protective immunity against reinfection with hepatitis C virus. Science (1992) 4.94

A rapid and convenient method for the preparation and storage of competent bacterial cells. Nucleic Acids Res (1988) 4.86

Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci U S A (1996) 4.82

A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med (1991) 4.79

A virus discovery method incorporating DNase treatment and its application to the identification of two bovine parvovirus species. Proc Natl Acad Sci U S A (2001) 4.62

Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses. J Virol (1987) 4.49

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology (1990) 4.43

Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis (1980) 4.28

Hepatitis C in hospital employees with needlestick injuries. Ann Intern Med (1991) 4.24

MULTIPLE POLYPOSIS OF THE COLON: A FAMILIAL DISEASE. Ann Surg (1937) 4.16

Non-A, non-B hepatitis in chimpanzees and marmosets. J Infect Dis (1981) 4.15

Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol (1993) 4.13

Hepatitis C virus: an infectious molecular clone of a second major genotype (2a) and lack of viability of intertypic 1a and 2a chimeras. Virology (1999) 4.04

Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol (2002) 3.83

Genetic and experimental evidence for cross-species infection by swine hepatitis E virus. J Virol (1998) 3.73

Sequence analysis of the 5' noncoding region of hepatitis C virus. Proc Natl Acad Sci U S A (1992) 3.72

Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay. Proc Natl Acad Sci U S A (1989) 3.67

Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci U S A (1994) 3.56

Evidence for in vitro replication of hepatitis C virus genome in a human T-cell line. Proc Natl Acad Sci U S A (1992) 3.55

A microtiter solid-phase radioimmunoassay for hepatitis A antigen and antibody. J Immunol (1976) 3.53

At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proc Natl Acad Sci U S A (1993) 3.37

Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med (1975) 3.31

Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis virus aetiology. Lancet (1980) 3.31

Australia antigen: large-scale purification from human serum and biochemical studies of its proteins. J Virol (1971) 3.28

Rapid and sensitive method for the detection of serum hepatitis B virus DNA using the polymerase chain reaction technique. J Clin Microbiol (1989) 3.19

Propagation of human hepatitis A virus in African green monkey kidney cell culture: primary isolation and serial passage. Infect Immun (1981) 3.18

Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol (1994) 3.06

ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates. J Infect Dis (1993) 3.06

Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature (1984) 3.03

Effectiveness of active physical training as treatment for long-standing adductor-related groin pain in athletes: randomised trial. Lancet (1999) 3.03

A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature (1983) 3.02

Frequency of antibody to hepatitis-associated antigen as measured by a new radioimmunoassay technique. J Immunol (1971) 2.98

Microtiter solid-phase radioimmunoassay for hepatitis B antigen. Appl Microbiol (1973) 2.96

Molecular cloning and characterization of hepatitis A virus cDNA. Proc Natl Acad Sci U S A (1983) 2.92

Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck. Proc Natl Acad Sci U S A (1984) 2.87

The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol (1993) 2.84

Hepatitis A virus cDNA and its RNA transcripts are infectious in cell culture. J Virol (1987) 2.83

Sequence analysis of the core gene of 14 hepatitis C virus genotypes. Proc Natl Acad Sci U S A (1994) 2.83

Delta hepatitis agent: structural and antigenic properties of the delta-associated particle. Infect Immun (1984) 2.81

A color test for the measurement of antibody to the non-acid-forming human Mycoplasma species. Am J Epidemiol (1966) 2.81

Transmissible agent in non-A, non-B hepatitis. Lancet (1978) 2.78

Non-A, non-B hepatitis: ultrastructural evidence for two agents in experimentally infected chimpanzees. Science (1979) 2.78

Transcripts of a chimeric cDNA clone of hepatitis C virus genotype 1b are infectious in vivo. Virology (1998) 2.76

Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. J Immunol (2000) 2.73

Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees. Proc Natl Acad Sci U S A (2000) 2.70

Compact organization of the hepatitis B virus genome. Hepatology (1989) 2.70

Determining the size of non-A, non-B hepatitis virus by filtration. J Infect Dis (1987) 2.68

Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. N Engl J Med (1976) 2.67

Characterization of a prototype strain of hepatitis E virus. Proc Natl Acad Sci U S A (1992) 2.64

Enzyme-linked immunosorbent assay for detection of hepatitis A antigen in stool and antibody to hepatitis A antigen in sera: comparison with solid-phase radioimmunoassay, immune electron microscopy, and immune adherence hemagglutination assay. J Clin Microbiol (1978) 2.64

MECKEL'S DIVERTICULUM IN ACUTE ABDOMINAL EMERGENCIES. Ann Surg (1933) 2.63

Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J Infect Dis (1995) 2.63

A complement-fixation test for measuring Australia antigen and antibody. J Infect Dis (1969) 2.58

Branched-chain amino acid metabolism. Annu Rev Nutr (1984) 2.58

In vivo analysis of the 3' untranslated region of the hepatitis C virus after in vitro mutagenesis of an infectious cDNA clone. Proc Natl Acad Sci U S A (1999) 2.56

Complete nucleotide sequence of an attenuated hepatitis A virus: comparison with wild-type virus. Proc Natl Acad Sci U S A (1987) 2.56

Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group. Ann Intern Med (1994) 2.55

IDIOPATHIC ULCERATIVE COLITIS: A REVIEW OF 149 CASES WITH PARTICULAR REFERENCE TO THE VALUE OF, AND INDICATIONS FOR SURGICAL TREATMENT. Ann Surg (1935) 2.48

Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J Clin Microbiol (1997) 2.48

Hepatitis B virus produced by transfected Hep G2 cells causes hepatitis in chimpanzees. Proc Natl Acad Sci U S A (1987) 2.46

Biophysical properties of Australia antigen. J Virol (1969) 2.45

Hepatitis C virus: detection of intracellular virus particles by electron microscopy. Hepatology (1996) 2.44

Experimental infection of chimpanzees with hepatitis A virus. J Infect Dis (1975) 2.41

Clinical and serological analysis of transfusion-associated hepatitis. Lancet (1975) 2.41

Hepatitis B and hepatitis C in emergency department patients. N Engl J Med (1992) 2.39

Comparative pathogenesis of infection of pigs with hepatitis E viruses recovered from a pig and a human. J Clin Microbiol (2001) 2.38

Cross-bridges mediate anterograde and retrograde vesicle transport along microtubules in squid axoplasm. J Cell Biol (1985) 2.32

Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. Proc Natl Acad Sci U S A (1992) 2.30

Incidence and significance of antibodies to delta antigen in hepatitis B virus infection. Lancet (1979) 2.29

Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study. Ann Intern Med (1978) 2.29